Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 17Unknown 8Recruiting 8Active not recruiting 5Terminated 4Not yet recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Triple Negative Breast Neoplasms 1

Interventions

Trastuzumab 78Capecitabine 59Cyclophosphamide 54Paclitaxel 52Docetaxel 50Letrozole 44Fulvestrant 43Lapatinib 34Doxorubicin 31Carboplatin 31Vinorelbine 30Bevacizumab 29Anastrozole 28pembrolizumab 26exemestane 24Tamoxifen 23Gemcitabine 22Radiotherapy 21Albumin-Bound Paclitaxel 19Taxes 17Everolimus 17Epirubicin 15pertuzumab 13Ado-Trastuzumab Emtansine 13130-nm albumin-bound paclitaxel 13palbociclib 12Magnetic Resonance Spectroscopy 12liposomal doxorubicin 11atezolizumab 11Filgrastim 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Breast Neoplasms × Mastectomy × Clear all
NCT00210236 2025-10-20

AXIL95

Institut Bergonié

Phase 3 Terminated
625 enrolled 8 charts
Breast

Breast Neoplasms

NCT01234532 2022-05-03

0927GCC

University of Maryland, Baltimore

Phase 2 Terminated
5 enrolled 7 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01167192 2016-12-30

Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer

Washington University School of Medicine

Phase 2 Terminated
10 enrolled 8 charts
Breast

Breast Neoplasms

NCT00603408 2016-08-19

Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer

Washington University School of Medicine

Phase 2 Terminated
5 enrolled 7 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡